MedPath
FDA Approval

PredniSONE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
QPharma Inc
DUNS: 030620888
Effective Date
December 8, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Prednisone(10 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Hikma Pharmaceuticals USA Inc.

080189610

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Northwind Pharmaceuticals, LLC

QPharma Inc

Hikma Pharmaceuticals USA Inc.

036986393

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PredniSONE

Product Details

NDC Product Code
42708-045
Application Number
ANDA084122
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 8, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
Code: VB0R961HZTClass: ACTIBQuantity: 10 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath